Cargando…

Move for Change Part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson’s disease

BACKGROUND AND PURPOSE: The 1997 European Parkinson’s Disease Association’s (EPDA) Charter for People with Parkinson’s disease (PD) outlines their rights in terms of standards of care. It states that all patients have the right to: be referred to a doctor with a special interest in PD; receive an ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Bloem, BR, Stocchi, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489042/
https://www.ncbi.nlm.nih.gov/pubmed/21967281
http://dx.doi.org/10.1111/j.1468-1331.2011.03532.x
_version_ 1782248711067271168
author Bloem, BR
Stocchi, F
author_facet Bloem, BR
Stocchi, F
author_sort Bloem, BR
collection PubMed
description BACKGROUND AND PURPOSE: The 1997 European Parkinson’s Disease Association’s (EPDA) Charter for People with Parkinson’s disease (PD) outlines their rights in terms of standards of care. It states that all patients have the right to: be referred to a doctor with a special interest in PD; receive an accurate diagnosis; have access to support services; receive continuous care; and take part in managing their illness. Move for Change is a three-part series of pan-European patient surveys based on this Charter. METHODS: This first survey, consisting of 23 questions, focusing on the initial two points of the Charter, was administered online through the EPDA and affiliated patient associations’ Web sites. Of 2149 forms received from 35 European countries, 2068 (96.2%) were analyzed, with the remainder excluded, mainly due to incomplete responses. RESULTS: The majority of patients were diagnosed within 2 years from the onset of first symptoms (82.7%; range, <1 year to ≥5 years). In relation to diagnosis delivery, 45.3% of patients stated that it was ‘poor’ or ‘very poor’. During the 2 years following diagnosis, 43.8% of respondents had never seen a PD specialist. Care was usually overseen by generically active neurologists (92.5%) or family doctors (81.0%), with considerable overlap between the two. CONCLUSIONS: These data highlight challenges that patients with PD face during the period of diagnosis, despite introduction of the Charter. These findings can assist healthcare professionals and policy makers in improving the level of care for patients and their families across Europe, and we offer suggestions about how this can be achieved.
format Online
Article
Text
id pubmed-3489042
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-34890422012-11-05 Move for Change Part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson’s disease Bloem, BR Stocchi, F Eur J Neurol Original Article BACKGROUND AND PURPOSE: The 1997 European Parkinson’s Disease Association’s (EPDA) Charter for People with Parkinson’s disease (PD) outlines their rights in terms of standards of care. It states that all patients have the right to: be referred to a doctor with a special interest in PD; receive an accurate diagnosis; have access to support services; receive continuous care; and take part in managing their illness. Move for Change is a three-part series of pan-European patient surveys based on this Charter. METHODS: This first survey, consisting of 23 questions, focusing on the initial two points of the Charter, was administered online through the EPDA and affiliated patient associations’ Web sites. Of 2149 forms received from 35 European countries, 2068 (96.2%) were analyzed, with the remainder excluded, mainly due to incomplete responses. RESULTS: The majority of patients were diagnosed within 2 years from the onset of first symptoms (82.7%; range, <1 year to ≥5 years). In relation to diagnosis delivery, 45.3% of patients stated that it was ‘poor’ or ‘very poor’. During the 2 years following diagnosis, 43.8% of respondents had never seen a PD specialist. Care was usually overseen by generically active neurologists (92.5%) or family doctors (81.0%), with considerable overlap between the two. CONCLUSIONS: These data highlight challenges that patients with PD face during the period of diagnosis, despite introduction of the Charter. These findings can assist healthcare professionals and policy makers in improving the level of care for patients and their families across Europe, and we offer suggestions about how this can be achieved. Blackwell Publishing Ltd 2012-03 /pmc/articles/PMC3489042/ /pubmed/21967281 http://dx.doi.org/10.1111/j.1468-1331.2011.03532.x Text en © 2011 The Author(s). European Journal of Neurology © 2011 EFNS http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms.
spellingShingle Original Article
Bloem, BR
Stocchi, F
Move for Change Part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson’s disease
title Move for Change Part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson’s disease
title_full Move for Change Part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson’s disease
title_fullStr Move for Change Part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson’s disease
title_full_unstemmed Move for Change Part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson’s disease
title_short Move for Change Part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson’s disease
title_sort move for change part i: a european survey evaluating the impact of the epda charter for people with parkinson’s disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489042/
https://www.ncbi.nlm.nih.gov/pubmed/21967281
http://dx.doi.org/10.1111/j.1468-1331.2011.03532.x
work_keys_str_mv AT bloembr moveforchangepartiaeuropeansurveyevaluatingtheimpactoftheepdacharterforpeoplewithparkinsonsdisease
AT stocchif moveforchangepartiaeuropeansurveyevaluatingtheimpactoftheepdacharterforpeoplewithparkinsonsdisease